Skip to main content
. 2023 Feb 21;24(5):4272. doi: 10.3390/ijms24054272

Figure 5.

Figure 5

Prognostic and immunological implications of TGFBR1 in hepatocellular carcinoma (HCC) patients. (a) Survival analysis of HCC patients according to TGFBR1 expression in The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA_LIHC). (b) Survival analysis of HCC patients according to expression of two miRs (miRs: hsa-miR-101-3p and hsa-miR-490-3p) in TCGA_LIHC. (c) Survival analysis of HCC patients according to expression of TGFBR1 and the two miRs in TCGA_LIHC. (d) Immune cell infiltration according to TGFBR1 expression as identified with TIMER analysis. (e) Correlation analysis of TGFBR1 expression with the Treg, M2, and MDSC cell markers in TCGA_LIHC. * p < 0.05; ** p < 0.01.